White label ELPA - ClinicalTrials.eu

Study on the Safety and Effectiveness of Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo

Not recruiting

3 1 1
Investigated Diseases:
- Vitiligo
Investigated Drugs:
- Dexamethasone
Study of Lenvatinib and Pembrolizumab for Patients with Recurrent or Metastatic Head and Neck Cancer After Platinum and Immunotherapy Treatment

Not recruiting

2 1 1 1
Investigated Diseases:
- Squamous cell carcinoma of head and neck
Investigated Drugs:
Study Comparing 7-Day and 14-Day Treatment with Vancomycin, Linezolid, and Daptomycin for Patients with Uncomplicated Enterococcal Blood Infections

Not recruiting

3 1 1 1
Investigated Diseases:
- Bacterial infection
Investigated Drugs:
Study on the Safety and Effects of Tolvaptan for Infants and Young Children with Autosomal Recessive Polycystic Kidney Disease

Not recruiting

3 1 1
Investigated Diseases:
- Congenital cystic kidney disease
Investigated Drugs:
- Tolvaptan
Study on the Effects of Verekitug (UPB-101) for Adults with Severe Asthma

Not recruiting

2 1
Investigated Drugs:
- Human Igg1 Kappa Monoclonal Antibody Against Crlf2
Study on the Long-Term Safety and Efficacy of Oral Ozanimod for Patients with Moderate to Severe Crohn’s Disease

Not recruiting

3 1 1
Investigated Diseases:
- Crohn’s disease
Investigated Drugs:
- Ozanimod
+9
Study on Apocynin and Paeonol for Knee Osteoarthritis Pain Relief in Adults

Not recruiting

2 1 1
Investigated Diseases:
- Osteoarthritis
Investigated Drugs:
Study on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma

Not recruiting

3 1 1 1
Investigated Drugs:
Study on the Effects of Dirocaftor, Posenacaftor, and Nesolicaftor for Adults with Cystic Fibrosis

Not recruiting

2 1
Investigated Diseases:
- Cystic fibrosis
Investigated Drugs:
+3
Study on Ribociclib, Alpelisib, and Letrozole for Adults with Advanced Hormone Receptor-Positive Breast Cancer

Not recruiting

1 1 1 1
Investigated Diseases:
- Breast cancer
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies